Researcher.Life Logo

Pharmacogenomics Journal : Impact Factor & More

eISSN: 1473-1150pISSN: 1470-269X

Key Metrics

CiteScore
6.5
H-Index
93
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacogenomics Journal

Pharmacogenomics Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacogenomics Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacogenomics Journal

Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies.
  • 15 May 2026
  • The pharmacogenomics journal
FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis.
  • 5 May 2026
  • The pharmacogenomics journal
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing.
  • 29 Apr 2026
  • The pharmacogenomics journal
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
  • 24 Apr 2026
  • The pharmacogenomics journal
Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy.
  • 23 Apr 2026
  • The pharmacogenomics journal
A randomized trial to evaluate attitudes regarding pharmacogenomics among pregnant and pediatric populations: design and baseline characteristics.
  • 23 Apr 2026
  • The pharmacogenomics journal
Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies.
  • 15 May 2026
  • The pharmacogenomics journal
FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis.
  • 5 May 2026
  • The pharmacogenomics journal
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing.
  • 29 Apr 2026
  • The pharmacogenomics journal
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
  • 24 Apr 2026
  • The pharmacogenomics journal
Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy.
  • 23 Apr 2026
  • The pharmacogenomics journal
A randomized trial to evaluate attitudes regarding pharmacogenomics among pregnant and pediatric populations: design and baseline characteristics.
  • 23 Apr 2026
  • The pharmacogenomics journal

FAQs on Pharmacogenomics Journal